Uric acid and survival in chronic heart: Failure validation and application in metabolic, functional, and hemodynamic staging

Stefan D. Anker; Wolfram Doehner; Mathias Rauchhaus; Rakesh Sharma; Darrel Francis; Christoph Knosalla; Constantinos H. Davos; Mariantonietta Cicoira; Waqar Shamim; Michel Kemp; Robert Segal; Karl Josef Osterziel; Francisco Leyva; Roland Hetzer; Piotr Ponikowski; Andrew J S Coats

doi:10.1161/01.CIR.0000065637.10517.A0

Uric acid and survival in chronic heart: Failure validation and application in metabolic, functional, and hemodynamic staging

Stefan D. Anker, Wolfram Doehner, Mathias Rauchhaus, Rakesh Sharma, Darrel Francis, Christoph Knosalla, Constantinos H. Davos, Mariantonietta Cicoira, Waqar Shamim, Michel Kemp, Robert Segal, Karl Josef Osterziel, Francisco Leyva, Roland Hetzer, Piotr Ponikowski, Andrew J S Coats

Istituto San Raffaele Pisana

Research output: Contribution to journal › Article › peer-review

Abstract

Background - Serum uric acid (UA) could be a valid prognostic marker and useful for metabolic, hemodynamic, and functional (MFH) staging in chronic heart failure (CHF). Methods and Results - For the derivation study, 112 patients with CHF (age 59±12 years, peak oxygen consumption [V̇o₂] 17±7 mL/kg per minute) were recruited. In separate studies, we validated the prognostic value of UA (n=182) and investigated the relationship between MFH score and the decision to list patients for heart transplantation (n=120). In the derivation study, the best mortality predicting UA cutoff (at 12 months) was 565 μmol/L (9.50 mg/dL) (independently of age, peak V̇o₂, left ventricular ejection fraction, diuretic dose, sodium, creatinine, and urea; P2 ≤14 mL/kg per min (MFH score 3), 12-month survival was lowest (31%) compared with patients with 2 (64%), 1 (77%), or no (98%, P

Original language	English
Pages (from-to)	1991-1997
Number of pages	7
Journal	Circulation
Volume	107
Issue number	15
DOIs	https://doi.org/10.1161/01.CIR.0000065637.10517.A0
Publication status	Published - Apr 22 2003

Keywords

Heart failure
Hemodynamics
Prognosis

ASJC Scopus subject areas

Physiology
Cardiology and Cardiovascular Medicine

Access to Document

10.1161/01.CIR.0000065637.10517.A0

Fingerprint Dive into the research topics of 'Uric acid and survival in chronic heart: Failure validation and application in metabolic, functional, and hemodynamic staging'. Together they form a unique fingerprint.

Cite this

Anker, S. D., Doehner, W., Rauchhaus, M., Sharma, R., Francis, D., Knosalla, C., Davos, C. H., Cicoira, M., Shamim, W., Kemp, M., Segal, R., Osterziel, K. J., Leyva, F., Hetzer, R., Ponikowski, P., & Coats, A. J. S. (2003). Uric acid and survival in chronic heart: Failure validation and application in metabolic, functional, and hemodynamic staging. Circulation, 107(15), 1991-1997. https://doi.org/10.1161/01.CIR.0000065637.10517.A0

Uric acid and survival in chronic heart : Failure validation and application in metabolic, functional, and hemodynamic staging. / Anker, Stefan D.; Doehner, Wolfram; Rauchhaus, Mathias; Sharma, Rakesh; Francis, Darrel; Knosalla, Christoph; Davos, Constantinos H.; Cicoira, Mariantonietta; Shamim, Waqar; Kemp, Michel; Segal, Robert; Osterziel, Karl Josef; Leyva, Francisco; Hetzer, Roland; Ponikowski, Piotr; Coats, Andrew J S.

In: Circulation, Vol. 107, No. 15, 22.04.2003, p. 1991-1997.

Research output: Contribution to journal › Article › peer-review

Anker, SD, Doehner, W, Rauchhaus, M, Sharma, R, Francis, D, Knosalla, C, Davos, CH, Cicoira, M, Shamim, W, Kemp, M, Segal, R, Osterziel, KJ, Leyva, F, Hetzer, R, Ponikowski, P & Coats, AJS 2003, 'Uric acid and survival in chronic heart: Failure validation and application in metabolic, functional, and hemodynamic staging', Circulation, vol. 107, no. 15, pp. 1991-1997. https://doi.org/10.1161/01.CIR.0000065637.10517.A0

Anker, Stefan D. ; Doehner, Wolfram ; Rauchhaus, Mathias ; Sharma, Rakesh ; Francis, Darrel ; Knosalla, Christoph ; Davos, Constantinos H. ; Cicoira, Mariantonietta ; Shamim, Waqar ; Kemp, Michel ; Segal, Robert ; Osterziel, Karl Josef ; Leyva, Francisco ; Hetzer, Roland ; Ponikowski, Piotr ; Coats, Andrew J S. / Uric acid and survival in chronic heart : Failure validation and application in metabolic, functional, and hemodynamic staging. In: Circulation. 2003 ; Vol. 107, No. 15. pp. 1991-1997.

@article{b23d1c492f504fcab375d6ac3c60dca6,

title = "Uric acid and survival in chronic heart: Failure validation and application in metabolic, functional, and hemodynamic staging",

abstract = "Background - Serum uric acid (UA) could be a valid prognostic marker and useful for metabolic, hemodynamic, and functional (MFH) staging in chronic heart failure (CHF). Methods and Results - For the derivation study, 112 patients with CHF (age 59±12 years, peak oxygen consumption [{\.V}o2] 17±7 mL/kg per minute) were recruited. In separate studies, we validated the prognostic value of UA (n=182) and investigated the relationship between MFH score and the decision to list patients for heart transplantation (n=120). In the derivation study, the best mortality predicting UA cutoff (at 12 months) was 565 μmol/L (9.50 mg/dL) (independently of age, peak {\.V}o2, left ventricular ejection fraction, diuretic dose, sodium, creatinine, and urea; P2 ≤14 mL/kg per min (MFH score 3), 12-month survival was lowest (31%) compared with patients with 2 (64%), 1 (77%), or no (98%, P",

keywords = "Heart failure, Hemodynamics, Prognosis",

author = "Anker, {Stefan D.} and Wolfram Doehner and Mathias Rauchhaus and Rakesh Sharma and Darrel Francis and Christoph Knosalla and Davos, {Constantinos H.} and Mariantonietta Cicoira and Waqar Shamim and Michel Kemp and Robert Segal and Osterziel, {Karl Josef} and Francisco Leyva and Roland Hetzer and Piotr Ponikowski and Coats, {Andrew J S}",

year = "2003",

month = apr,

day = "22",

doi = "10.1161/01.CIR.0000065637.10517.A0",

language = "English",

volume = "107",

pages = "1991--1997",

journal = "Circulation",

issn = "0009-7322",

publisher = "Lippincott Williams and Wilkins",

number = "15",

}

TY - JOUR

T1 - Uric acid and survival in chronic heart

T2 - Failure validation and application in metabolic, functional, and hemodynamic staging

AU - Anker, Stefan D.

AU - Doehner, Wolfram

AU - Rauchhaus, Mathias

AU - Sharma, Rakesh

AU - Francis, Darrel

AU - Knosalla, Christoph

AU - Davos, Constantinos H.

AU - Cicoira, Mariantonietta

AU - Shamim, Waqar

AU - Kemp, Michel

AU - Segal, Robert

AU - Osterziel, Karl Josef

AU - Leyva, Francisco

AU - Hetzer, Roland

AU - Ponikowski, Piotr

AU - Coats, Andrew J S

PY - 2003/4/22

Y1 - 2003/4/22

N2 - Background - Serum uric acid (UA) could be a valid prognostic marker and useful for metabolic, hemodynamic, and functional (MFH) staging in chronic heart failure (CHF). Methods and Results - For the derivation study, 112 patients with CHF (age 59±12 years, peak oxygen consumption [V̇o2] 17±7 mL/kg per minute) were recruited. In separate studies, we validated the prognostic value of UA (n=182) and investigated the relationship between MFH score and the decision to list patients for heart transplantation (n=120). In the derivation study, the best mortality predicting UA cutoff (at 12 months) was 565 μmol/L (9.50 mg/dL) (independently of age, peak V̇o2, left ventricular ejection fraction, diuretic dose, sodium, creatinine, and urea; P2 ≤14 mL/kg per min (MFH score 3), 12-month survival was lowest (31%) compared with patients with 2 (64%), 1 (77%), or no (98%, P

AB - Background - Serum uric acid (UA) could be a valid prognostic marker and useful for metabolic, hemodynamic, and functional (MFH) staging in chronic heart failure (CHF). Methods and Results - For the derivation study, 112 patients with CHF (age 59±12 years, peak oxygen consumption [V̇o2] 17±7 mL/kg per minute) were recruited. In separate studies, we validated the prognostic value of UA (n=182) and investigated the relationship between MFH score and the decision to list patients for heart transplantation (n=120). In the derivation study, the best mortality predicting UA cutoff (at 12 months) was 565 μmol/L (9.50 mg/dL) (independently of age, peak V̇o2, left ventricular ejection fraction, diuretic dose, sodium, creatinine, and urea; P2 ≤14 mL/kg per min (MFH score 3), 12-month survival was lowest (31%) compared with patients with 2 (64%), 1 (77%), or no (98%, P

KW - Heart failure

KW - Hemodynamics

KW - Prognosis

UR - http://www.scopus.com/inward/record.url?scp=0037461111&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037461111&partnerID=8YFLogxK

U2 - 10.1161/01.CIR.0000065637.10517.A0

DO - 10.1161/01.CIR.0000065637.10517.A0

M3 - Article

C2 - 12707250

AN - SCOPUS:0037461111

VL - 107

SP - 1991

EP - 1997

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 15

ER -